Search research articles
Contact Us
Filters
Showing results (301-310 of 343) with videos related to
Page
of 35
Sort By:
American Journal of Hematology
|
March 10, 2025
Depth of Response From Fixed-Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia
Jonas Paludo, Jithma P Abeykoon, Nirosha D Perera, et al.
Blood Cancer Journal
|
February 2, 2020
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas
Manit Munshi, Xia Liu, Jiaji G Chen, et al.
British Journal of Haematology
|
December 15, 2015
Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia
Lian Xu, Zachary R Hunter, Nicholas Tsakmaklis, et al.
Haematologica
|
November 12, 2020
A prognostic index predicting survival in transformed Waldenström macroglobulinemia
Eric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, et al.
Journal of Geriatric Oncology
|
July 7, 2023
Real-world experience in older patients with diffuse large B-cell lymphoma treated in Latin America: A study by the Latin American study group of lymphoproliferative disorders (GELL)
Myrna Candelaria, Luis Villela, Maria-Alejandra Torres-Viera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 24, 2024
Simplified Risk Stratification Model for Patients With Waldenström Macroglobulinemia
Saurabh Zanwar, Jennifer Le-Rademacher, Eric Durot, et al.
The Lancet. Oncology
|
December 14, 2016
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial
Meletios A Dimopoulos, Judith Trotman, Alessandra Tedeschi, et al.
Blood Advances
|
March 7, 2022
A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas
Manit Munshi, Xia Liu, Amanda Kofides, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 30, 2021
POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis
Artur Jurczyszyn, Jorge J Castillo, Magdalena Olszewska-Szopa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2022
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma
Tomas Jelinek, Renata Bezdekova, David Zihala, et al.
Page
of 35
Search research articles
Search
Showing results (301-310 of 343) with videos related to
Sort By:
Page
of 35
American Journal of Hematology
|
March 10, 2025
Depth of Response From Fixed-Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia
Jonas Paludo, Jithma P Abeykoon, Nirosha D Perera, et al.
Blood Cancer Journal
|
February 2, 2020
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas
Manit Munshi, Xia Liu, Jiaji G Chen, et al.
British Journal of Haematology
|
December 15, 2015
Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia
Lian Xu, Zachary R Hunter, Nicholas Tsakmaklis, et al.
Haematologica
|
November 12, 2020
A prognostic index predicting survival in transformed Waldenström macroglobulinemia
Eric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, et al.
Journal of Geriatric Oncology
|
July 7, 2023
Real-world experience in older patients with diffuse large B-cell lymphoma treated in Latin America: A study by the Latin American study group of lymphoproliferative disorders (GELL)
Myrna Candelaria, Luis Villela, Maria-Alejandra Torres-Viera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 24, 2024
Simplified Risk Stratification Model for Patients With Waldenström Macroglobulinemia
Saurabh Zanwar, Jennifer Le-Rademacher, Eric Durot, et al.
The Lancet. Oncology
|
December 14, 2016
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial
Meletios A Dimopoulos, Judith Trotman, Alessandra Tedeschi, et al.
Blood Advances
|
March 7, 2022
A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas
Manit Munshi, Xia Liu, Amanda Kofides, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 30, 2021
POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis
Artur Jurczyszyn, Jorge J Castillo, Magdalena Olszewska-Szopa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2022
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma
Tomas Jelinek, Renata Bezdekova, David Zihala, et al.
Page
of 35